Table 5.
Comparison of demographic and biological characteristics of patients colonized by ESBL-E in TBRI and Beaujon
| Character | Number of patients (%) | |
|---|---|---|
| Beaujon (n = 13) | TBRI (n = 45) | |
| Sex | ||
| Male | 9 (69) | 18 (40) |
| Female | 4 (31) | 27 (60) |
| Average age, years (range) | 51 (33–67) | 53 (19–75) |
| Previous hospitalization | ||
| <3 months | 9 (69) | 5 (11) |
| 3 months to 3 years | 3 (23) | 4 (9) |
| >3 years | 0 | 9 (20) |
| None | 1 (8) | 22 (49)* |
| Not available | 0 | 5 (11) |
| Main pathology | ||
| Chronic hepatitis | 9 | 35 |
| HCV | 4 (31) | 15 (34)* |
| HCV + bilharziasis | 0 | 20 (44)* |
| HBV | 1 (8) | 0 |
| Alcoholic | 3 (23)* | 0 |
| Mixed (alcoholic + HCV) | 1 (8) | 0 |
| Other diseases | 4 (31) | 10 (22) |
| Comorbidity | 6 (46) | 9 (20) |
| Cirrhosis/ascites | 6 (46) | 29 (64) |
| Mean MELD (range) | 17 (7–25) | 16 (5–39) |
| Mean PT (range) | 73 (39–110) | 62 (14–100) |
| Mean AST (range) | 55 (14–108) | 68 (12–294) |
| Mean ALT (range) | 51 (16–123) | 56 (22–207) |
| Mean total bilirubin (range) | 64 (6–181) | 81 (9–554) |
| Mean creatinine (range) | 110 (59–265) | 103 (44–256) |
MELD, Model for end-stage liver disease; PT, prothrombin time; AST, aspartate transaminase; ALT, alanine transaminase.
ESBL-E, Extended spectrum β-lactamase-producing enterobacteria.
*
P ⩽ 0.05.